scispace - formally typeset
M

M. Di Rocco

Researcher at Istituto Giannina Gaslini

Publications -  69
Citations -  1562

M. Di Rocco is an academic researcher from Istituto Giannina Gaslini. The author has contributed to research in topics: Compound heterozygosity & Microcephaly. The author has an hindex of 26, co-authored 69 publications receiving 1445 citations. Previous affiliations of M. Di Rocco include Boston Children's Hospital & University of Genoa.

Papers
More filters
Journal ArticleDOI

Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2

TL;DR: The clinical and molecular findings suggest that Torg, NAO and Winchester syndromes are allelic disorders that form a clinical spectrum.
Journal ArticleDOI

β-Galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement

TL;DR: Although the authors could not directly correlate the presence of cardiac abnormalities with specific genetic lesions, the mutations identified in patients with cardiomyopathy fell in the GLB1 cDNA region common to the lysosomal enzyme and the Hβ‐Gal‐related protein, also known as the elastin binding protein (EBP).
Journal ArticleDOI

Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers

TL;DR: The classical form is mainly characterised, in affected hemizygous males, by angiokeratoma, acroparaesthesias, hypohidrosis, pains, fever crises, and involvement of the kidneys, brain, and heart, while the cardiac variant is characterised by symptoms restricted to cardiac abnormalities.
Journal ArticleDOI

Arg113His mutation in eIF2B as cause of leukoencephalopathy in adults

TL;DR: The data suggest that the Arg113His mutation in eIF2Bε is particularly mild and should be considered in the differential diagnosis of adult diffuse leukoencephalopathies, independent of whether there are associated clinical signs, an episodic course, or MRI shows white matter rarefaction/cystic degeneration.